420411
Kanamycin Sulfate, Streptomyces kanamyceticus, Cell Culture-Tested
Wenn Sie allgemeine Fragen haben, wenden Sie sich bitte an unseren Kundenservice:
Merck KGaA
Frankfurter Str. 250
64293 Darmstadt
Germany
Telefon: +49 6151 72-0
Fax: +49 6151 72 2000
15 Februar 2012
wird geladen
An aminoglycoside antibiotic effective against Gram-positive and Gram-negative organisms. Inhibitor of protein biosynthesis that acts on the 30S ribosome, causing misreading of the genetic code. May cause renal damage and ototoxicity.
Contains >98% kanamycin A. Potency: ≥750 µg/mg
Recommended working concentration: 100 µg/ml.
| Produktinformationen | |||
|---|---|---|---|
| Form | White to off-white solid | ||
| Primary Target | protein biosynthesis that acts on the 30S ribosome | ||
| Chemische Formel | C18H36N4O11 · H2SO4 | ||
| RTECS | NZ3225030 | ||
| CAS-Nummer | 25389-94-0 | ||
| Merck USA index | 14, 5281 | ||
| Lager- und Versandinformationen | |||
|---|---|---|---|
| Lagerkategorie | +15°C to +30°C | ||
| Ship |
Ambient Temperature Only
Carcinogenic / Teratogenic |
||
| Sicherheitshinweise | |||
|---|---|---|---|
| S-Satz |
S: 26-36/37/39-45 |
||
| R-Satz |
R: 36/37/38-42/43-60-61 |
||
